Production efficiency improved for 4-nitro-3,5-dimethylpyridine-N-oxide in chemical synthesis, suggesting reduced safety risks.
4-nitro-3,5-dimethylpyridine- N -oxide is a key intermediate in the preparation of esomeprazole, which involves oxidation followed by nitration reactions. However, the conventional batch reactor method necessitates use of excess peroxide, and nitric acid/sulfuric acid mixture which faces serious safety and environmental issues. Herein, we report efficient production of 4-nitro-3,5-dimethylpyridine- N -oxide using the microchannel technology which not only increases the yield but also significantly reduces safety risks and waste output.
No takes yet. Share an insight, caveat, or question.
Wei-Si Li (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: